Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-01 Sale | 2023-08-11 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Executive Officer | 16,713 | $0.94 | $15,710 | 83,193 (Direct) | View |
| 2022-08-03 Sale | 2022-08-05 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Executive Officer | 10,594 | $1.72 | $18,222 | 99,906 (Direct) | View |
| 2021-07-21 Sale | 2022-01-14 8:30 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Executive Officer | 33,500 | $6.1 | $204,350 | 54,500 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 1,000 | $11.35 | $11,350 | 88,000 (Direct) | View |
| 2021-01-14 Sale | 2021-01-15 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 9,000 | $12.02 | $108,150 | 89,000 (Direct) | View |
| 2020-12-15 Sale | 2020-12-17 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 1,000 | $10.48 | $10,480 | 98,000 (Direct) | View |
| 2020-12-11 Sale | 2020-12-15 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 1,405 | $10.05 | $14,120 | 99,000 (Direct) | View |
| 2020-11-11 Sale | 2020-11-13 8:00 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 595 | $10.05 | $5,980 | 100,405 (Direct) | View |
| 2020-10-14 Sale | 2020-10-16 8:02 pm | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 4,000 | $10.05 | $40,200 | 101,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-14 Option Award | 2024-06-17 4:30 pm | N/A 2034-06-13 | Xilio Therapeutics Inc. | XLO | ROSS ROBERT W. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-09-08 Disposition | 2023-09-08 4:00 pm | N/A N/A | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Executive Officer | 483,193 | $0 | 0 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-13 4:30 pm | N/A 2033-06-11 | Xilio Therapeutics Inc. | XLO | ROSS ROBERT W. Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:00 pm | N/A 2033-03-01 | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Executive Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:08 pm | N/A 2032-06-14 | Xilio Therapeutics Inc. | XLO | ROSS ROBERT W. Director | 26,400 | $0 | 26,400 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 8:00 pm | N/A 2032-03-01 | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Executive Officer | 415,000 | $0 | 469,500 (Direct) | View |
| 2021-02-12 Option Award(A) | 2021-03-11 8:00 pm | N/A 2031-02-12 | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 484,280 | $0 | 484,280 (Direct) | View |
| 2021-02-12 Option Award | 2021-03-03 8:18 pm | N/A 2031-02-12 | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 484,280 | $0 | 484,280 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A 2030-02-03 | Surface Oncology Inc. | SURF | ROSS ROBERT W. Chief Medical Officer | 80,000 | $0 | 185,000 (Direct) | View |